We use cookies to analyze the performance of our website. If you continue to visit our website you are consenting to our use of cookies.

Yes No More Info

Why Drug Development Requires Flexibility In Clinical Trial Design

Innovation in drug development requires flexibility in the clinical trial design, not merely standardisation, according to Prof Dr Geerd Weyer, Managing Director at ICRC-Weyer clinical contract research organisation. In a recent interview Prof Weyer claims that every clinical trial is unique and must be designed and treated as such.

We use cookies to analyze the performance of our website. If you continue to visit our website you are consenting to our use of cookies.

Yes No More Info